CORE

Latest SEC Filings & News for CORE

1 most recent filing and news item mentioning CORE. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/CORE/news?limit=20"

Pull CORE filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OfferingJul 17, 2026Neutral

Cero Therapeutics Amends Note and Secures $671,600 Advance

Cero Therapeutics entered a second amended and restated convertible note for up to $2.09 million, securing an initial $671,600 advance. This financing agreement represents a liquidity boost for the clinical-stage biopharmaceutical company.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.